06.27.18

Gemini version available ♊︎

J A Kemp Pushing the Boundaries of Patent Scope in Europe With Antibodies and SPCs

Posted in Europe, Patents at 5:30 am by Dr. Roy Schestowitz

Even the USPTO isn’t too clear on antibody patent policies

“…currently there is an apparent tension between the USPTO guideline with which antibody patents are granted and the case law with which the validity of existing antibody patents is determined. The antibody “exception” of the USPTO written description guideline says that a claim for an isolated antibody binding to an antigen satisfies the written description requirement even when the specification only describes the antigen and does not have working or detailed prophetic examples of antibodies that bind to the antigen. United States Patent and Trademark Office, Revised Interim Written Description Guidelines Training Materials (1999) at 59–60 [hereinafter Training Materials]; United States Patent and Trademark Office, Written Description Training Materials, Revision 1 (March 25, 2008) at 45–46 [hereinafter Revised Training Materials]. In Centocor v. Abbott, the Court of Appeals for the Federal Circuit (“Federal Circuit”) held that a patentee cannot claim an antibody unless the specification describes it, even if he/she fully characterizes the antigen, and the court vacated a $1.67 billion jury verdict, the largest patent infringement award in U.S. history. The relationship between Centocor and the USPTO guideline is not clear. Although many commentators generally agree that Centocor at least restricts the scope of the antibody exception, they disagree over interpretation of the post-Centocor antibody exception.” (Source: “Written Description Problems of the Monoclonal Antibody Patents after Centocor v. Abbott”)

Summary: Patent maximalism is still a serious and an urgent issue for the EPO to tackle; the Office seems to have been dedicated to the interests of litigation firms rather than science and technology sectors

THERE are two types of patents that we oppose; one is software patents and the other is ‘life’ patents, or patents which pertain to what already exists in nature (or manipulated slightly from what’s in nature) as those aren’t actually inventions but monopolies on life itself. Ramifications include food prices, breeding, public health (e.g. cancer effects), and access to medicine. The EPC sets limits (if not outright bans) on both types of patents, but the EPO‘s management doesn’t give a damn. Production, production, production (where “production” gets measured in terms of granted patents).

“The EPC sets limits (if not outright bans) on both types of patents, but the EPO’s management doesn’t give a damn.”There have been many articles lately about António Campinos; it’s all about trademarks and hours ago it was reported that his agency (EU-IPO) had passed France.com to someone else, in effect taking it away from its longtime owner. Remember that Campinos is a Frenchman and recall the trademark stories about Battistelli at INPI. It does make one wonder what sorts of maximalists we deal with here.

“We’ve recently noticed J A Kemp, a law firm, repeatedly promoting patent maximalism across Europe.”Where does the EPO go from here as far as patent scope is concerned? Will Campinos undo the great damage caused by Battistelli on purely technical grounds (never mind the corruption and abuses)?

We’ve recently noticed J A Kemp, a law firm, repeatedly promoting patent maximalism across Europe. John Leeming from J A Kemp wrote about software patents earlier this year and earlier this month they spoke about antibodies, with the obligatory promotion of Supplementary Protection Certificates (SPCs)]. J A Kemp was again mentioned here very recently (it does promotion of “Patenting Antibodies at the EPO”).

Well, SPCs (related to UPC) are in many headlines this month because of a decision/announcement from European authorities and yesterday we spotted Mondaq’s spam/promotion, with statements like “ask your usual J A Kemp contact.”

It’s titled “Antibodies In The European Patent Office” (similar but not directly related to patents on life) and it speaks of patentability criteria as follows:

The European Patent Office (EPO) applies the same basic patentability criteria to antibodies as to other inventions, but it can sometimes appear that antibodies are treated as a special case. For an explanation of the basic approach adopted by the EPO, please see our related briefing Antibodies in the European Patent Office – Basic Principles or ask your usual J A Kemp contact. The present briefing is intended to develop those Basic Principles into a guide to the drafting and prosecution of patent applications for antibody inventions.

The briefing focuses on the most common type of antibody invention at the present time – namely monoclonal antibody products for which the target and any associated disease indications are already known. We also provide guidance on ensuring your antibody claims are appropriate to support future applications for Supplementary Protection Certificates (SPCs).

It’s no secret that some of the biggest pushers for UPC are large pharmaceutical firms, which want to then impose SPCs and cement their monopolies. If the EPO obeys their malicious agenda, which threatens to spread software patents in the whole of Europe in one fell swoop (we know that the EPO recklessly grants these), then our challenges with the EPO as far as patent scope and litigation scope (UPC) are concerned will take priority.

“We’ve spoken about these issues for nearly a decade, but it’s only in recent years that technology firms put their weight behind groups and studies that demonstrate what we spoke about, hoping to sway politicians accordingly.”Our concern about this isn’t isolated. IP2Innovate, which fronts for technology firms, has just released this press release and told us about it. Amaury Libbrecht, Policy Manager at IP2Innovate, told us about “supporting innovation in Europe through a balanced Europe patent system…”

Notice the repeated warnings about patent trolls in Europe — a subject which patent trolls' front groups like IAM (together with Team UPC) tried hard to deny.

The latest from IP2Innovate, Libbrecht has told us, “identifies some imbalances in Europe’s patent legal system (i.e. quasi automatic injunctions, bifurcation/injunction gap, ineffective fee-shifting, poor patent quality and lack of transparency) and point out solutions to address these problems…”

We’ve spoken about these issues for nearly a decade, but it’s only in recent years that technology firms put their weight behind groups and studies that demonstrate what we spoke about, hoping to sway politicians accordingly.

Share in other sites/networks: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • Reddit
  • email

Decor ᶃ Gemini Space

Below is a Web proxy. We recommend getting a Gemini client/browser.

Black/white/grey bullet button This post is also available in Gemini over at this address (requires a Gemini client/browser to open).

Decor ✐ Cross-references

Black/white/grey bullet button Pages that cross-reference this one, if any exist, are listed below or will be listed below over time.

Decor ▢ Respond and Discuss

Black/white/grey bullet button If you liked this post, consider subscribing to the RSS feed or join us now at the IRC channels.

DecorWhat Else is New


  1. IRC Proceedings: Sunday, November 28, 2021

    IRC logs for Sunday, November 28, 2021



  2. Links 29/11/2021: Linux 5.16 RC3 and Lots of Patent Catch-up

    Links for the day



  3. By 2022 0% of 'News' Coverage About Patents Will Be Actual Journalism (Patent Litigation Sector Has Hijacked the World Wide Web to Disseminate Self-Promotional Misinformation)

    Finding news about the EPO is almost impossible because today’s so-called ‘news’ sites are in the pockets of Benoît Battistelli, António Campinos, and their cohorts who turned the EPO into a hub of litigation, not science; this is part of an international (worldwide) problem because financial resources for journalism have run out, and so the vacuum is filled/replaced almost entirely by Public Relations (PR) and marketing



  4. Trying to Appease Those Who Never Liked Free Software or Those Who Blindly Loved All Patent Monopolies to Begin With

    It’s crystal clear that trying to appease everyone, all the time, is impossible; in the case of the EPO, for example, we hope that exposing Team Battistelli/Campinos helps raise awareness of the harms of patent maximalism, and when speaking about Free software — whilst occasionally bashing the alternatives (proprietary) — we hope to convince more people to join the “Good Fight”



  5. Links 28/11/2021: Laravel 8.73 Released, GitHub Offline for Hours

    Links for the day



  6. IRC Proceedings: Saturday, November 27, 2021

    IRC logs for Saturday, November 27, 2021



  7. Links 27/11/2021: Nvidia’s DLSS Hype and Why GNU/Linux Matters

    Links for the day



  8. [Meme] Linus Gabriel Sebastian Takes GNU/Linux for a (Tail)'Spin'

    If you’re trying to prove that GNU/Linux is NOT Windows, then “haha! Well done…”



  9. GNU/Linux is for Freedom and It'll Gain Many Users When (or Where) People Understand What Software (or Computing) Freedom Means

    Software that respects people's freedom (and by extension privacy as well) is an alluring proposition; those who choose to try GNU/Linux for the wrong reasons are likely the wrong target audience for advocates



  10. Amid Reports of Microsoft's Competition Crimes in Europe...

    European companies are complaining, but they seem to overlook the principal aspect of an imperialistic system with bottomless pockets (almost 30 trillion dollars in debt already; US national debt soared again last month); Microsoft is shielded by a political system with military (“defence”) as bailout budget to help cushion international expansion for data grab and technical leverage, as we've seen in the case of EPO (this is all political, not technical, and should thus be treated as a political/corruption issue)



  11. Is Linus Trolling the GNU/Linux Community?

    This new video responds to what many sites have been provoked into amplifying



  12. Links 27/11/2021: Tux Paint 0.9.27 and SeaMonkey 1.1.19 in EasyOS

    Links for the day



  13. [Meme] Keeping Our Distance From Microsoft

    The OSI is the dagger, the Linux Foundation is the knife, and many others are the sword by which Microsoft tries to get into the very heart of GNU/Linux and extinguish the Free software movement



  14. Microsoft Edge Encourages Indebted Americans to Guilt-spend Just in Time for Christmas

    Guest post by Ryan, reprinted with permission



  15. IRC Proceedings: Friday, November 26, 2021

    IRC logs for Friday, November 26, 2021



  16. 38+ Years of GNU and 19+ Years of FSF Associate Membership

    “On November 25, 2002,” Wikipedia notes, “the FSF launched the FSF Associate Membership program for individuals.” As the above video points out, it all started almost 40 years ago.



  17. Gemini as a Platform for Gamers

    Contrary to what people often assume (or are led to assume), even without client-side scripting Gemini can accomplish a great deal; early adopters, many of whom are technical, test the limits of the very minimalistic (by design and intention) specification



  18. Improved Workflows: Achievement Unlocked

    Today we've completed a bunch of small projects that can make us more efficient (e.g. more Daily Links per day, more articles); the above video was recorded many hours ago to accompany the outline below



  19. Links 26/11/2021: New Complaint About Microsoft Competition Crimes in Europe, EuroLinux 8.5, GhostBSD 21.11.24, and Kiwi TCMS 10.5 Released

    Links for the day



  20. Links 26/11/2021: F35 Elections, Whonix 16.0.3.7, OSMC's November Refresh With Kodi 19.3

    Links for the day



  21. IRC Proceedings: Thursday, November 25, 2021

    IRC logs for Thursday, November 25, 2021



  22. IRC Proceedings: Wednesday, November 24, 2021

    IRC logs for Wednesday, November 24, 2021



  23. Links 25/11/2021: PHP 8.1.0 Released and Linux 5.15.5

    Links for the day



  24. IBM as Master of Hypocrisy

    Free software projects and Free software developers have long been humiliated by corporations of Western misogynists, falsely claiming that the Free software community isn’t inclusive enough (these are shameless projection tactics; as a matter of public record, the exact opposite is true) and even the eradication of supposedly offensive language isn’t something IBM takes seriously



  25. Links 25/11/2021: LibreOffice 7.2.3 and Mesa 21.2.6 Released

    Links for the day



  26. [Meme] So Desperate That Edge Cannot Even Exceed 4% That They Block Rival Web Browsers

    Linux/Android/Free Software/GNU (they go by very many names/brands) may continue to grow to the point where Windows is as irrelevant as Blackberry; this means that Microsoft’s grip on the Web too has slipped — to the point where Microsoft frantically uses 'bailout' money to hijack LinkedIn, GitHub, etc. (it also rebrands almost everything as "Azure" or clown to fake a perception of growth)



  27. Windows Vista Service Pack 11 (Vista 11) Has Failed to Curb the Growth of GNU/Linux

    Windows market share continues to decrease in spite of billions of dollars spent bribing the media for fake hype, especially in light of a new Windows Service Pack (SP), Vista SP 11



  28. Links 25/11/2021: Proton 6.3-8 and Linux Mint Compared to Ubuntu

    Links for the day



  29. 3.5 Years Later the 'Master' of Fedora is Still Microsoft and IBM Cannot Be Bothered to Alter Git Branch Names (Refuting or Ignoring Its Very Own Directive About Supposedly Racially-Insensitive Terms)

    Today we demonstrate the hypocrisy of IBM; years after telling us that we should shun the term "master" and repeatedly insisting it had a racist connotation at least 65 Fedora repositories, still controlled by Microsoft, still use "master"



  30. Changing the Arrangement While News is a Bit Slow(er)

    I've made it easier for myself to keep abreast of things like IRC channels and networks (incidentally, a day ago Freenode reopened to anonymous logins) and I've improved monitoring of the Web sites, Gemini capsule etc. (this video is unplanned and improvised)


RSS 64x64RSS Feed: subscribe to the RSS feed for regular updates

Home iconSite Wiki: You can improve this site by helping the extension of the site's content

Home iconSite Home: Background about the site and some key features in the front page

Chat iconIRC Channel: Come and chat with us in real time

Recent Posts